Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
09/2000
09/27/2000EP1037603A1 Membrane virus host range mutations and their uses as vaccine substrates
09/27/2000EP0901465B1 Compounds with anti-inflammatory and immunosuppressive activities
09/27/2000EP0885188B1 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
09/27/2000EP0777488A4 Composition and method for allogeneic mononuclear cell immunotherapy
09/27/2000EP0688224B1 A mutant crp-protein and methods and materials for making and using it
09/27/2000CN1268176A Improved anti-IgE antibodies and method of improving polypeptides
09/27/2000CN1268140A Monocyclic L-nucleosides, analogs and uses thereof
09/27/2000CN1268054A Combination therapy comprising amlodipine and a statin compound
09/27/2000CN1268052A Therapeutic combinations comprising amlodipin and atorvastatin
09/27/2000CN1268050A Pharmaceutical composition for combination of piperidinoalkanol-decongestant
09/27/2000CN1267549A Oral immune globulin preparation and its preparing process
09/27/2000CN1267519A Immune regulator, immune regulator food and immune regulator fodder
09/27/2000CN1056836C 3,5-disubstituted and 3,4,5-trisubstituted 2-isoxazolines and isoxazoles and producing process thereof and their use as medicaments
09/27/2000CN1056768C Chinese herb medicine for treating different autoimmunity diseases and its preparing method
09/26/2000US6124456 Adenosine antagonists
09/26/2000US6124322 An aqueous thalidomide solution comprising a pure enantiomer of thalidomide dissolved in an isotonic glucose solution
09/26/2000US6124320 Treating with non-sedating antihistamines without causing cardiac arrhythmias
09/26/2000US6124296 Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
09/26/2000US6124288 Phosphodiesterase iv inhibitors
09/26/2000US6124095 Human nucleotide pyrophosphohydrolase-2
09/26/2000US6123949 A vaccine which comprises an effective immunizing amount of the genetically engineered fowlpox virus designated s-fpv-043, useful for immunizing the animal against disease caused by fowlpox virus and newcastle disease virus
09/26/2000US6123943 NF-KB activity inhibitor
09/26/2000US6123916 For treating disorders with an aetiology comprising or associated with excess of gh-secretion
09/21/2000WO2000055633A2 Methods of screening for colorectal cancer modulators
09/21/2000WO2000055371A1 27 human secreted proteins
09/21/2000WO2000055362A1 Deleted sequences in m. bovis bcg/m. bovis or m. tuberculosis, method for detecting mycobacteria using said sequences and vaccines
09/21/2000WO2000055352A2 50 human secreted proteins
09/21/2000WO2000055343A2 Retrovirus producting cells utilizing a high multiplicity of transduction
09/21/2000WO2000055332A2 Human regulators of intracellular phosphorylation
09/21/2000WO2000055321A2 Vertebrate protein slit, dna sequence encoding it and uses thereof
09/21/2000WO2000055199A1 47 human secreted proteins
09/21/2000WO2000055198A1 50 human secreted proteins
09/21/2000WO2000055194A2 Tuberculosis antigens and methods of use therefor
09/21/2000WO2000055183A1 Method for refolding molecules of polypeptides containing ig domains
09/21/2000WO2000055162A2 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
09/21/2000WO2000055161A1 6-substituted biaryl purine derivatives as potent cyclin/cdk inhibitors and antiproliferative agents
09/21/2000WO2000055159A2 Substituted aza-oxindole derivatives
09/21/2000WO2000055155A2 Heterocyclic compounds as adenosine deaminase inhibitors
09/21/2000WO2000055154A1 Modified amino-acid amides as cgrp antagonists
09/21/2000WO2000055152A1 Aromatic heterocyclic compounds as anti-inflammatory agents
09/21/2000WO2000055144A1 Amine derivatives as protease inhibitors
09/21/2000WO2000055139A2 Heterocyclic urea and related compounds useful as anti-inflammatory agents
09/21/2000WO2000055134A1 Substituted 1-oxo- and 1,3-dioxoisoindolines and their use in pharmaceutical compositions for reducing inflammatory cytokine levels
09/21/2000WO2000055127A1 Gamma-ketoacid dipeptides as inhibitors of caspase-3
09/21/2000WO2000055126A2 N-cyanomethylamides as protease inhibitors
09/21/2000WO2000055125A2 N-cyanomethyl amides as protease inhibitors
09/21/2000WO2000055114A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof
09/21/2000WO2000055072A2 Aerosol metering valve
09/21/2000WO2000054815A2 Expression of dna or proteins in c. elegans
09/21/2000WO2000054804A1 Use of tgf-beta inhibitors for treating cerebral disorders
09/21/2000WO2000054803A2 Immunostimulatory nucleic acids and antigens
09/21/2000WO2000054802A2 Method of expressing antigens on the surface of antigen presenting cells by photochemical internalization
09/21/2000WO2000054797A2 Pharmaceutical compositions comprising tgf-beta
09/21/2000WO2000054790A1 Immunostimulant bacterial membrane fractions in cancer treatment
09/21/2000WO2000054789A1 Bacterial membrane fractions with adjuvant effect
09/21/2000WO2000054786A1 Methods and compositions for tolerizing hosts for long term survival of tissue transplants
09/21/2000WO2000054763A2 Pharmaceutical compositions comprising polymorphic forms of dehydroepiandrosterone
09/21/2000WO2000040716A3 Soluble receptor br43x2 and methods of using them for therapy
09/21/2000WO2000040225A3 Inhibition of tnf activity
09/21/2000WO2000039303A3 Modified hiv env polypeptides
09/21/2000WO2000038785A3 Methods for treating certain diseases using naaladase inhibitors
09/21/2000WO2000027207A8 Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof
09/21/2000WO2000020039A9 Methods and adjuvants for stimulating mucosal immunity
09/21/2000WO2000004865A3 Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives
09/21/2000DE19911510A1 Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Bicyclic heterocycles, pharmaceutical compositions containing them, their use and process for their preparation
09/21/2000DE19910419A1 Zielzellspezifische, multivalente Proteine (MVP) Target cell-specific, multivalent proteins (MVP)
09/21/2000CA2369319A1 Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
09/21/2000CA2368148A1 Novel compounds and compositions as protease inhibitors
09/21/2000CA2368122A1 Novel compounds and compositions as protease inhibitors
09/21/2000CA2368068A1 27 human secreted proteins
09/21/2000CA2367917A1 Bacterial membrane fractions with adjuvant effect
09/21/2000CA2367862A1 Gamma-ketoacid dipeptides as inhibitors of caspase-3
09/21/2000CA2367409A1 Metering valve
09/21/2000CA2367357A1 Method
09/21/2000CA2367354A1 6-substituted biaryl purine derivatives as potent cyclin/cdk inhibitors and antiproliferative agents
09/21/2000CA2367352A1 Amine derivatives as protease inhibitors
09/21/2000CA2367340A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof
09/21/2000CA2367211A1 Immunostimulant bacterial membrane fractions in cancer treatment
09/21/2000CA2365655A1 Retrovirus producting cells utilizing a high multiplicity of transduction
09/21/2000CA2365214A1 Vertebrate protein slit, dna sequence encoding it and uses thereof
09/21/2000CA2364739A1 Regulators of intracellular phosphorylation
09/21/2000CA2364635A1 47 human secreted proteins
09/21/2000CA2364630A1 50 human secreted proteins
09/21/2000CA2364568A1 Method for refolding molecules of polypeptides containing ig domains
09/21/2000CA2361939A1 Modified amino acid amides, pharmaceutical compositions containing these compounds and processes for preparing them
09/21/2000CA2361770A1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
09/21/2000CA2332767A1 Dhea composition and method
09/20/2000EP1036794A1 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof
09/20/2000EP1036327A2 Hla-e binding
09/20/2000EP1036191A2 Method for identifying ihbitors of g-protein coupled receptor hibef51
09/20/2000EP1036188A1 ribG
09/20/2000EP1036187A1 Process for the preparation of immunomodulatory polysaccharides from aloe
09/20/2000EP1036175A1 Human brain derived kcnq2 potassium channel
09/20/2000EP1036164A1 Chemokine alpha-5
09/20/2000EP1036076A1 Novel compounds
09/20/2000EP1036059A1 Adamantane derivatives
09/20/2000EP1036058A1 Adamantane derivatives
09/20/2000EP1035869A1 Chemically and thermally stable norastemizole formulations
09/20/2000EP1035867A1 Transdermal delivery of particulate vaccine compositions
09/20/2000EP1035866A2 Mixed lipopeptide micelles for inducing an immune response and their therapeutic uses
1 ... 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 ... 1172